TriSalus Life Sciences, Inc. (TLSI) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Revenue from TriNav System in the United States | 8.9M | FY2026-Q1 |
| Net Sales Growth (Year-Over-Year) | 52.00 percent | FY2025-Q2 |
| Net Sales Growth (Sequential) | 22.00 percent | FY2025-Q2 |
Back to TLSI overview · TLSI earnings · TLSI holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.